IP Reps and Warranties, Explained

Term sheets get the headlines, but the reps and warranties are where founders quietly take on real, personal financial risk. These clauses look like boilerplate, so people skim them — then discover, months after closing, that one false sentence about who owns the code costs seven figures out of escrow. This guide walks through the IP reps you’ll actually sign, what each one means, and how to negotiate them so you’re not underwriting problems you didn’t know you had.

What are IP reps and warranties, and why do they matter?

A representation is a statement of fact about the present or past (“the company owns all of its source code”). A warranty is a promise that the statement is true, backed by a remedy if it isn’t. In practice, deal lawyers use the phrase “reps and warranties” as one bundled concept, and the IP section is usually the longest and most heavily negotiated block in the whole agreement.

They matter because they do two jobs at once:

• Diligence forcing function. Drafting accurate reps forces you and your counsel to actually verify what you own. Most IP problems surface here, not in the data room. That’s why smart founders run an IP audit before they raise rather than discovering a gap while a term sheet is on the table.
• Risk allocation. The reps decide who eats the cost if something is wrong. A false rep is a breach, and the buyer or lead investor can recover their losses — often directly from the founders’ proceeds.

In venture financings the reps are usually lighter and the remedies are typically limited — a negotiated price adjustment, a rescission claim, or a securities-law action rather than a formal indemnity; in an M&A stock or asset purchase agreement, they’re extensive and backed by real money set aside at closing. The stakes scale with the deal. For the bigger picture on how diligence and deal terms fit together, see the IP diligence for fundraising and M&A hub.

Which IP representations will you actually sign?

Every deal is bespoke, but a modern tech SPA almost always includes these IP reps. Read each as a promise you are personally standing behind:

• Ownership and title. The company owns or has valid rights to all IP used in the business, free of liens and encumbrances. This is where invention-assignment agreements get tested — if a founder or contractor never assigned their work, you don’t actually own it. Confirm chain of title before you sign; see who owns your startup’s IP and the startup IP checklist.
• Non-infringement. The company’s products and operations don’t infringe, misappropriate, or violate any third party’s patents, trademarks, copyrights, or trade secrets. This is the scariest rep because patent infringement can be innocent and unknowable — which is exactly why the knowledge qualifier fight (below) centers here.
• Validity and enforceability. Registered IP (patents, trademarks, copyrights) is subsisting, valid, and enforceable, and maintenance fees are paid. A lapsed trademark renewal or an unpaid patent maintenance fee is a classic schedule item.
• No pending or threatened claims. No litigation, opposition, cease-and-desist, or demand letter is pending or, to the company’s knowledge, threatened. That old demand letter you ignored belongs on a schedule.
• Sufficiency of assets. The IP the company owns or licenses is sufficient to conduct the business as currently run (and sometimes “as planned”). This catches the case where a critical tool is licensed personally by a founder, or a key dependency sits under a co-founder’s GitHub account.
• Open-source compliance. The company’s use of open-source software complies with all applicable licenses, and no OSS is incorporated in a way that would require disclosing or licensing proprietary code (the “copyleft”/GPL trap). Buyers scan your codebase for this. Get ahead of it with open-source licensing for startups.
• Confidentiality and trade secrets. The company has taken reasonable measures to protect its trade secrets and has confidentiality agreements in place. Weak protection here can undercut the value of what you’re selling — the whole point of the trade-secrets case archive is that courts only protect what you actually guarded.
• Data and privacy. Increasingly bundled in: the company complies with applicable privacy laws and its own privacy policy, and (post-2023) that AI-generated or AI-assisted outputs and training data don’t create ownership or infringement gaps. See who owns AI output and AI clauses in contracts.

What are knowledge qualifiers, and why fight over them?

A knowledge qualifier is the single most valuable phrase a founder can add: “to the company’s knowledge.” It converts an absolute promise into a promise only about what you actually knew.

Compare:

• Absolute: “The company’s products do not infringe any third-party patent.” — You’re liable even for a patent you’d never heard of.
• Qualified: “To the company’s knowledge, the company’s products do not infringe any third-party patent.” — You’re only liable if you knew (or should have known).

Two sub-negotiations decide how much protection you actually get:

1. Whose knowledge counts? The agreement defines the “knowledge parties” — often the CEO, CTO, and a few others by name. Keep this list short and named, not “any employee.”
2. Actual vs. constructive knowledge. “Actual knowledge” means what those people genuinely knew. “Knowledge after reasonable inquiry” (constructive knowledge) obligates them to have investigated — a much broader, riskier standard. Push for actual knowledge, especially on the non-infringement rep, where a freedom-to-operate search you never ran shouldn’t be held against you.

Buyers resist knowledge qualifiers because they shift the risk of unknown problems back to the buyer. The typical compromise: fully qualify the unknowable reps (third-party patent infringement), leave the reps you should control (ownership, chain of title, executed assignments) unqualified.

How do disclosure schedules limit your exposure?

If knowledge qualifiers are your shield, disclosure schedules are your armor. These are the numbered attachments where you list every exception to the reps: each in-license and out-license, every security interest, all registered IP and its status, pending disputes and demand letters, and your open-source bill of materials.

The mechanism is simple and powerful: anything you properly disclose generally can’t be the basis of an indemnification claim, because the buyer bought the company knowing about it. Disclosure converts a hidden landmine into a priced, accepted risk.

Two practical rules:

• Over-disclose within reason. When in doubt, schedule it. A disclosed messy license is far cheaper than an undisclosed one that becomes a breach.
• Mind “anti-sandbagging” and general-disclosure clauses. Some agreements say a disclosure against one rep counts against all reps “where the relevance is reasonably apparent”; others require you to cross-reference. Know which regime you’re in so a disclosure lands where you need it.

Thin, rushed schedules are one of the most common causes of post-closing indemnity fights. Building them is the payoff of doing an IP audit before you raise — the audit is the raw material for the schedules.

What do materiality, survival, caps, and baskets mean?

These four concepts govern how much a breach can actually cost you.

• Materiality qualifiers. Reps are often limited to what’s “material” or has a “Material Adverse Effect,” so a trivial, technical breach doesn’t trigger liability. Buyers sometimes negotiate a materiality scrape, which reads materiality out of the reps when calculating damages — a term that meaningfully increases seller risk, so watch for it.
• Survival periods. Reps don’t live forever. General reps commonly survive 12 to 24 months after closing; the clock is how long the buyer has to bring a claim. Fundamental reps — including, usually, IP ownership — survive much longer (often 3-6 years or the statute of limitations), because they go to what the buyer thought it was paying for.
• Caps. The maximum recoverable for a rep breach. General reps are frequently capped at 10-20% of the purchase price (or the escrow amount). Fundamental reps, including IP, are often capped much higher — sometimes at the full purchase price.
• Baskets and deductibles. A basket (often ~0.5-1% of deal value) is a threshold the buyer’s losses must exceed before any claim is allowed. A “tipping basket” pays from dollar one once crossed; a “true deductible” pays only the excess above the threshold.

Whether IP reps sit in the “general” bucket or the “fundamental” bucket is one of the most consequential negotiations in the deal, because it can swing your maximum exposure from 15% of the price to 100% of it.

How do indemnification, escrow, and holdbacks work?

Indemnification is the actual remedy: if a rep is breached, the sellers must make the buyer whole for the resulting losses. But a promise to pay is worthless if the money is already spent, so buyers secure it.

• Escrow. A portion of the purchase price — historically 10-15%, though R&W insurance has pushed this lower — is held by a third party for the survival period. IP breaches get paid out of here first.
• Holdback. The buyer simply keeps part of the price and releases it later if no claims arise. Functionally similar to escrow, but the buyer holds the cash.
• Special IP indemnities. Buyers sometimes carve out a specific indemnity for a known IP risk (say, a pending patent troll suit) with its own cap and survival, separate from the general regime.

For founders, the key questions are how much is held back, for how long, and — critically — whether liability is several (each founder liable for their own share) or joint and several (any founder can be pursued for the whole amount). Push for several liability capped at your pro-rata proceeds. These mechanics get especially sharp in talent-driven deals; see IP in acquihires, where the “sufficiency” and assignment reps interact with retention terms.

When does rep and warranty insurance make sense?

Rep and warranty (R&W) insurance has reshaped mid-market and larger M&A. Instead of clawing money back from founders, the buyer recovers breach losses — including IP breaches — from an insurer.

How it plays out:

• Buyer-side policies are the norm. The buyer holds a policy and files claims against it, which lets sellers negotiate a smaller escrow and lower caps — sometimes a near “walkaway” deal where the policy, not the founders, backstops most reps.
• Cost. Premiums typically run 2-4% of the coverage limit, plus underwriting fees, with a retention (deductible) often around 0.5-1% of enterprise value that steps down over the first year.
• Underwriting scrutiny. Insurers run their own diligence and will exclude known issues and anything poorly diligenced. Weak IP diligence or thin schedules lead to IP-specific exclusions — which defeats the purpose. Clean diligence literally lowers your risk transfer.

R&W insurance generally isn’t available or economical below roughly $20-30 million in deal size, so most seed and Series A financings rely on the escrow-and-indemnity structure instead. The same discipline that makes a policy cheap — verified ownership, complete schedules, clean open-source — is exactly what protects you when there’s no policy at all. That discipline starts with IP diligence for fundraising and M&A.

How do you negotiate and limit your IP-rep exposure?

You can’t refuse to give IP reps — no buyer closes without them — but you can shape them. A founder’s playbook:

• Qualify the unknowable, own the controllable. Insist on knowledge qualifiers for third-party infringement; accept unqualified reps only where you truly control the facts (executed assignments, filed registrations).
• Nail down chain of title before signing. Every founder, employee, and contractor should have a signed present-assignment (“hereby assigns”). Fixing this is far cheaper pre-deal than as a breach — start from the startup IP playbook.
• Over-invest in schedules. They’re your cheapest insurance. Disclose every license, dispute, encumbrance, and OSS dependency.
• Fight the materiality scrape and keep IP in the general (not fundamental) bucket where you can — or at least negotiate a separate, lower cap for the non-infringement rep.
• Cap and time-limit everything. Short survival, a real basket, a sensible cap, and several (not joint) liability proportional to your proceeds.
• Use R&W insurance where deal size supports it to move risk off your personal balance sheet.
• Read the definitions. “Company IP,” “knowledge,” “Material Adverse Effect,” and “Losses” are defined terms that quietly control everything — negotiate the definitions, not just the reps.

The bottom line

IP reps and warranties are where the abstract question “do we own our IP?” turns into concrete, personal financial exposure. The reps you’ll sign — ownership, non-infringement, validity, no claims, sufficiency, and open-source compliance — are non-negotiable in principle, but everything around them is negotiable: knowledge qualifiers, disclosure schedules, materiality, survival, caps, baskets, indemnification structure, and insurance. Founders who treat the reps as an afterthought fund other people’s problems out of escrow. Founders who run a real IP audit, verify their chain of title, and build thorough schedules turn the same clauses into a manageable, priced, and often insured risk.

This guide is general education, not legal advice, and does not create an attorney-client relationship. The scope and effect of reps, warranties, and indemnities turn on the exact contract language and your governing law — consult an attorney licensed in your jurisdiction before signing or negotiating a deal.